GB909055A - Pharmaceutical compositions containing aluminium allantoinate - Google Patents
Pharmaceutical compositions containing aluminium allantoinateInfo
- Publication number
- GB909055A GB909055A GB10510/60A GB1051060A GB909055A GB 909055 A GB909055 A GB 909055A GB 10510/60 A GB10510/60 A GB 10510/60A GB 1051060 A GB1051060 A GB 1051060A GB 909055 A GB909055 A GB 909055A
- Authority
- GB
- United Kingdom
- Prior art keywords
- allantoinate
- pharmaceutical compositions
- compositions containing
- allantoate
- containing aluminium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 title 1
- 229910052782 aluminium Inorganic materials 0.000 title 1
- 239000004411 aluminium Substances 0.000 title 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 229940036348 bismuth carbonate Drugs 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- -1 chlorhydroxyaluminium Chemical compound 0.000 abstract 1
- GMZOPRQQINFLPQ-UHFFFAOYSA-H dibismuth;tricarbonate Chemical compound [Bi+3].[Bi+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O GMZOPRQQINFLPQ-UHFFFAOYSA-H 0.000 abstract 1
- RBNPZEHAODHBPZ-UHFFFAOYSA-M dihydroxyaluminium Chemical compound O.O.NCC(=O)O[Al] RBNPZEHAODHBPZ-UHFFFAOYSA-M 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract 1
- 239000001685 glycyrrhizic acid Substances 0.000 abstract 1
- 235000019410 glycyrrhizin Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- FUFVKLQESJNNAN-UHFFFAOYSA-M homatropine methylbromide Chemical compound [Br-].C[N+]1(C)C(C2)CCC1CC2OC(=O)C(O)C1=CC=CC=C1 FUFVKLQESJNNAN-UHFFFAOYSA-M 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 abstract 1
- 235000019799 monosodium phosphate Nutrition 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 abstract 1
- 239000000741 silica gel Substances 0.000 abstract 1
- 229910002027 silica gel Inorganic materials 0.000 abstract 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract 1
- 239000001488 sodium phosphate Substances 0.000 abstract 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical composition for oral use in the treatment of gastro-intestinal disorders comprises calcium carbonate and one or both of dihydroxyaluminium allantoate and chlorhydroxyaluminium allantoate. The compositions may be in the form of tablets, cachets or capsules. Optional additions are (a) methyl homatropine bromide, (b) a non-toxic polyoxyethylene polyoxypropylene dispersing agent, (c) bismuth carbonate, (d) aluminium phosphate, (e) monosodium phosphate, (f) silica gel, (g) glycocoll, (h) titanium oxide and (i) glycyrrhizic acid.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB10510/60A GB909055A (en) | 1960-03-24 | 1960-03-24 | Pharmaceutical compositions containing aluminium allantoinate |
| FR853872A FR949M (en) | 1960-03-24 | 1961-02-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB10510/60A GB909055A (en) | 1960-03-24 | 1960-03-24 | Pharmaceutical compositions containing aluminium allantoinate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB909055A true GB909055A (en) | 1962-10-24 |
Family
ID=9969166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB10510/60A Expired GB909055A (en) | 1960-03-24 | 1960-03-24 | Pharmaceutical compositions containing aluminium allantoinate |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR949M (en) |
| GB (1) | GB909055A (en) |
-
1960
- 1960-03-24 GB GB10510/60A patent/GB909055A/en not_active Expired
-
1961
- 1961-02-25 FR FR853872A patent/FR949M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR949M (en) | 1961-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8700498D0 (en) | NOVEL PHARMACEOLOGICALLY ACTIVE COMPOUNDS | |
| DK37388D0 (en) | Steroid 5-alpha-reductase inhibitors | |
| MY101791A (en) | New benzimidazole derivatives | |
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| IL91276A0 (en) | Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases | |
| IT8367922A0 (en) | CARBOSTYRYL DERIVATIVE PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVE | |
| PH16119A (en) | New hydroxypropyl-triazole compound,their composition and medicinal use | |
| ZA818499B (en) | Agents for combating circulatory illnesses and their use | |
| AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
| GB2021409A (en) | Pharmaceutical composition | |
| GB909055A (en) | Pharmaceutical compositions containing aluminium allantoinate | |
| DE3371515D1 (en) | Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | |
| IL61989A (en) | 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them | |
| DE2963141D1 (en) | New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them | |
| ZA792262B (en) | Pharmaceutical compositions for use in the prophylaxis or treatment of angina pectoris | |
| DE3065087D1 (en) | Piperidine derivatives of 3-hydroxy-thiophene-2-carboxylic acid esters, their preparation, and pharmaceutical preparations containing them | |
| GB899059A (en) | Improvements in or relating to therapeutic compositions containing a pyridine derivative | |
| ZA843615B (en) | 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states | |
| DE3366925D1 (en) | Physiologically active pterocarpan compounds, methods for the isolation thereof and therapeutically active compositions containing them | |
| GB976096A (en) | Pharmaceutical compositions | |
| GB2012166A (en) | Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts. | |
| GB971239A (en) | Therapeutic composition having hypotensive and vasodilator activity | |
| AU439164B2 (en) | Oral compositions for treatment of hypercholes teremia | |
| AU433614B2 (en) | Oral compositions and methods for retarding dental caries and calculus | |
| AU252896B2 (en) | Therapeutic composition containing 4-hydroxybutyric acid or salts thereof |